Real-Time News FIRE NOW SIP Calculators

Easy-to-understand Financial Insights
that build Wealth.

Suit Of Products

Explore Dzambhala Pro

Biocon Biologics' Bengaluru Facilities Inspected by US FDA, Issues Form-483 with Observations

July 27, 2024, 7:31 p.m.

The US FDA conducted a combined cGMP (current Good Manufacturing Practice) and Pre-Licensing Inspection (PLI) at Biocon Biologics’ Facilities at Biocon Park, Bengaluru, India from July 15 to …

Unlock the Full Filing And Lot More

Access premium insights and stay ahead of the market with Dzambhala Pro.

BIOCON Regulatory